Increased Intratumoral Fluorothymidine Uptake Levels Following Multikinase Inhibitor Sorafenib Treatment in a Human Renal Cell Carcinoma Xenograft Model

Oncology Letters - Greece
doi 10.3892/ol.2013.1459
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

NRAS Mutations in Cutaneous T Cell Lymphoma (CTCL) Sensitize Tumors Towards Treatment With the Multikinase Inhibitor Sorafenib

Oncotarget
Oncology
2017English

Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Efficacy of Cryoablation Combined With Sorafenib for the Treatment of Advanced Renal Cell Carcinoma

International Journal of Hyperthermia
MedicineCancer ResearchRadiologicalPhysiologyUltrasound Technology
2019English

P450 Inhibitor Ketoconazole Increased the Intratumor Drug Levels and Antitumor Activity of Fenretinide in Human Neuroblastoma Xenograft Models

International Journal of Cancer
Cancer ResearchOncology
2017English

Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial

British Journal of Cancer
Cancer ResearchOncology
2011English

The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient-Derived Xenograft Models

Clinical Cancer Research
Cancer ResearchOncology
2015English

A Dosing/Cross-Development Study of the Multikinase Inhibitor Sorafenib in Patients With Pulmonary Arterial Hypertension

Clinical Pharmacology and Therapeutics
Pharmacology
2009English

5-Aza-2′-Deoxycytidine Suppresses Human Renal Carcinoma Cell Growth in a Xenograft Model via Up-Regulation of the Connexin 32 Gene

British Journal of Pharmacology
Pharmacology
2009English

Treatment in Established Human Renal Cell Carcinoma Heterotransplanted in Nude Mice

Japanese Journal of Urology
Urology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy